MGTX – meiragtx holdings plc - ordinary shares (US:NASDAQ)

News

ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
MeiraGTx (NASDAQ:MGTX) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership [Yahoo! Finance]
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors [Seeking Alpha]
MeiraGTx (NASDAQ:MGTX) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com